Physician profile
Juan Esnard
NPI 1225088289
$3,013.84
in general payments reported to CMS, 2019-2025
15 companies · $350 in 2025
The $350 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,246 · 2020: $12.82 · 2021: $115 · 2022: $120 · 2023: $14.93 · 2024: $156 · 2025: $350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $521.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $520.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,203.30 | 2019-2022 | |
| Shockwave Medical, INC | $149.81 | 2025 | |
| Boston Scientific Corporation | $131.78 | 2024 | |
| Teleflex LLC | $106.00 | 2025 | Turnpike |
| Kestra Medical Technology Services, INC. | $72.31 | 2025 | Assure Wcd |
| Pfizer INC. | $66.48 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $52.14 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $50.51 | 2019-2021 | |
| Alexion Pharmaceuticals, INC. | $45.41 | 2022 | |
| Amgen INC. | $39.47 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $30.91 | 2021 | |
| Edwards Lifesciences Corporation | $23.83 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Medtronic Vascular, INC. | $15.98 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $14.50 | 2021 | |
| Medtronic, INC. | $11.41 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juan Esnard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.